Global Veterinary Immunodiagnostics Market

Global Veterinary Immunodiagnostics Market Size, Share, Growth Analysis, By Product(Analyzers, Consumables), By Technology(ELISA, Radioimmune Assays), By Animal type(Companion animals, Livestock), By End-User(Reference laboratories, Veterinary Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35I2291 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 117 | Figures: 77

Global Veterinary Immunodiagnostics Market Insights

Veterinary Immunodiagnostics Market size was valued at USD 2183.35 million in 2019 and is poised to grow from USD 2375.1 million in 2023 to USD 4663.51 million by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

The rising incidence of animal disease, the availability of disease-specific immunodiagnostic tests, and improvements in immunodiagnostic technology all contribute to the market's expansion. Additionally, the rise in the number of pets and the demand for foods derived from animals both contribute to the expansion of this market. Opportunities for the expansion of this market are expected to be created by emerging economies. The development of the veterinary immunodiagnostics market, however, is anticipated to face significant obstacles due to the underdeveloped veterinary diagnostics infrastructure in developing nations.

There are more people and animals being tested because COVID-19 is becoming more common worldwide. Players and reference labs have also been prompted by this to create new and improved animal tests. The AVMA, CDC, USDA, American Association of Veterinary Laboratory Diagnosticians (AAVLD), National Association of State Public Health Veterinarians (NASPHV), and the National Assembly of State Animal Health Officials do not advocate routine COVID-19 testing of animals. Animal testing may be decided upon by public and animal health officials due to the constantly changing situation. The attending veterinarian, as well as representatives from the local, state, and/or federal public health and animal health departments, should jointly decide whether to conduct the test.

US Veterinary Immunodiagnostics Market  is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 2183.35 million

Largest Segment

Companion animals

Fastest Growth

Livestock

Growth Rate

8.8% CAGR

Global Veterinary Immunodiagnostics Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Veterinary Immunodiagnostics Market Size By Animal Type, 2021-2028 ($ Bn)
Global Veterinary Immunodiagnostics Market Size By Animal Type, 2021-2028 (%)

To get more reports on the above market click here to Buy The Report

Global Veterinary Immunodiagnostics Market Segmental Analysis

The global veterinary immunodiagnostics market is segmented based on product, technology, animal type, end-user and regions. Based on product the  Veterinary Immunodiagnostics Market is further sub segmented into analyzers and consumables segments. On the basis of technology, the Veterinary Immunodiagnostics Market can be bifurcated into ELISA, radioimmunoassay, rapid tests and other segments. On the basis of animal type, the segregation is based on companion animals and livestock segments. Based on end-users the market can be segregated into reference laboratories, veterinary hospitals and clinics, PoC testing sub segments. The regional insights of the Veterinary Immunodiagnostics Market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Veterinary Immunodiagnostics MarketAnalysis by Animal Type

The segment with the highest revenue in 2021 was companion animals, and growth is anticipated during the forecast period. This is due to factors such as the rise in pet ownership in developed nations, the popularity of pet insurance, the expansion of the global veterinary profession, and measures to control and prevent animal diseases. During the forecast period, the livestock segment will account for a sizable portion of the market. Growing global food production demand and awareness of animal health are two factors promoting the growth of this market.

Global Veterinary Immunodiagnostics Market By Animal Type , 2021(%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Veterinary Immunodiagnostics Market Regional Insights

Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary immunodiagnostics market. The expansion of products on the market, the sizable stakes held by the major players in the area, and the rising accessibility and affordability of early detection all contribute to this dominance. The market in Asia Pacific is anticipated to expand at the fastest rate during the forecast period due to rising pet adoption rates, zoonotic disease occurrences, and a rise in the need for diagnostics for infectious diseases in livestock.

Global Veterinary Immunodiagnostics Market By Geography, 2021 - 2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Veterinary Immunodiagnostics Market Dynamics

Veterinary Immunodiagnostics MarketDriver

  • At least 30 serious illnesses that affect people can be spread by animals. The majority of human infections are spread by livestock and companion animals (like dogs and cats) (such as pigs, chickens, cattle, goats, and camels). Major zoonotic illnesses that spread from animals to people include rabies, leptospirosis, cysticercosis, zoonotic tuberculosis, and gastrointestinal disease.
  • Additionally, transboundary diseases are now more common. For instance, foot-and-mouth disease (FMD), which has a 100% morbidity rate, was estimated to affect about 77% of the world's livestock in nations in Africa, the Middle East, and Asia, as well as in a small portion of South America (in susceptible cattle populations).
  • There is a zoonotic source for the COVID-19 global outbreak brought on by the SARS-CoV-2 virus. According to phylogenetic analysis, bats seem to be the COVID-19 virus' reservoir. Since there is typically little in the way of close contact between people and bats, it is more likely that the virus was transferred from other animal species that people handled to people. Currently unknown, this intermediate animal host or zoonotic source could be a domestic animal, a wild animal, or a domesticated wild animal. Globally, the COVID-19 pandemic has resulted in a significant loss of life and is an unprecedented threat to public health.

Veterinary Immunodiagnostics MarketRestraint 

  • The cost of caring for pets has significantly increased over the past ten years. Our research indicates that veterinary care is the second-highest expenditure category in the pet care industry. For instance, the US spent over US$ 18.11 billion on veterinary care, up 6.1%from the year before. A high-end procedure could cost anywhere between US$ 5,000 and US$ 20,000, according to PetMD, with low-to-medium pet care costs reaching US$ 250 to US$ 4,500 in veterinary offices.
  • For example, the cost of diagnostic procedures to determine antimicrobial sensitivity or the presence of an infection using PCR or other cutting-edge technologies is higher. Treatments rely heavily on cutting-edge products and techniques, but these products and techniques come at a very high cost in terms of materials and equipment and the cost of the actual treatment. Consequently, both pet owners and veterinarians are hesitant to spend so much on diagnostic procedures.

Request Free Customization of this report to help us to meet your business objectives.

Global Veterinary Immunodiagnostics Market Competitive Landscape

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or

Veterinary Immunodiagnostics Market Top Players Company Profiles 

Veterinary Immunodiagnostics Market Recent Developments

  • In April 2021, The Svanova product portfolio from Boehringer Ingelheim was acquired by INDICAL BIOSCIENCE GmbH (Germany), enabling INDICAL to expand its portfolio by 25 assays for livestock.
  • In January 2021, together with assistance from the CDC, Illumina (US) and Helix OpCo (US) improved the US national surveillance infrastructure to monitor the emergence and spread of new SARS-CoV-2 strains. The nation's current surveillance efforts to detect and characterize new SARS-CoV-2 variants will be significantly increased by Illumina's sequencing technology and expertise as well as Helix's nationwide COVID-19 testing footprint.

Global Veterinary Immunodiagnostics Key Market Trends

  • A number of zoonotic and vector-borne diseases are likely to become more common in the near future as a result of shifting social norms, habitat modification, the introduction of exotic vectors, and climate change. The need for quick and accurate diagnostic tools to stop these diseases will therefore drive the development of veterinary infectious disease diagnostics. According to the forecast, the development of companion animal medicine in developed nations will lead to further growth in the global market for veterinary infectious disease diagnostics. Furthermore, there is already a greater market demand for technologically advanced diagnostic techniques like RT PCR than there is for traditional diagnostic techniques.

Global Veterinary Immunodiagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the Global veterinary immunodiagnostics market is segmented based on product, technology, animal type, end-user and regions. The segment with the highest revenue in 2021 was companion animals, and growth is anticipated during the forecast period. This is due to factors such as the rise in pet ownership in developed nations, the popularity of pet insurance, the expansion of the global veterinary profession, and measures to control and prevent animal diseases. Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary infectious disease diagnostics market.

Report Metric Details
Market size value in 2023 USD 2183.35 million
Market size value in 2031 USD 4663.51 million
Growth Rate 8.8%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Analyzers, Consumables
  • Technology
    • ELISA, Radioimmune Assays, Rapid Tests, Others
  • Animal type
    • Companion animals, Livestock
  • End-User
    • Reference laboratories, Veterinary Hospitals, Clinics, PoC Testing
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Veterinary Immunodiagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Veterinary Immunodiagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Veterinary Immunodiagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Veterinary Immunodiagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Veterinary Immunodiagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Veterinary Immunodiagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Veterinary Immunodiagnostics Market size was valued at USD 2183.35 million in 2019 and is poised to grow from USD 2375.1 million in 2023 to USD 4663.51 million by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or 'IDEXX Laboratories, Inc. (US)', 'Zoetis Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'Heska Corporation', 'Abaxis, Inc.', 'Virbac SA', 'Neogen Corporation', 'BioMérieux SA', 'Idexx Reference Laboratories', 'Randox Laboratories Ltd.', 'VCA, Inc.', 'Covance Inc.', 'IDVet', 'INGENASA', 'Creative Diagnostics', 'Eurofins Scientific SE', 'ProtaTek International Inc.', 'Agrolabo S.p.A.', 'Fujirebio Inc.', 'Bio-Rad Laboratories, Inc.'

At least 30 serious illnesses that affect people can be spread by animals. The majority of human infections are spread by livestock and companion animals (like dogs and cats) (such as pigs, chickens, cattle, goats, and camels). Major zoonotic illnesses that spread from animals to people include rabies, leptospirosis, cysticercosis, zoonotic tuberculosis, and gastrointestinal disease.

A number of zoonotic and vector-borne diseases are likely to become more common in the near future as a result of shifting social norms, habitat modification, the introduction of exotic vectors, and climate change. The need for quick and accurate diagnostic tools to stop these diseases will therefore drive the development of veterinary infectious disease diagnostics. According to the forecast, the development of companion animal medicine in developed nations will lead to further growth in the global market for veterinary infectious disease diagnostics. Furthermore, there is already a greater market demand for technologically advanced diagnostic techniques like RT PCR than there is for traditional diagnostic techniques.

Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary immunodiagnostics market. The expansion of products on the market, the sizable stakes held by the major players in the area, and the rising accessibility and affordability of early detection all contribute to this dominance. The market in Asia Pacific is anticipated to expand at the fastest rate during the forecast period due to rising pet adoption rates, zoonotic disease occurrences, and a rise in the need for diagnostics for infectious diseases in livestock.

Veterinary Immunodiagnostics Market size was valued at USD 2183.35 million in 2019 and is poised to grow from USD 2375.1 million in 2023 to USD 4663.51 million by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or 'IDEXX Laboratories, Inc. (US)', 'Zoetis Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'Heska Corporation', 'Abaxis, Inc.', 'Virbac SA', 'Neogen Corporation', 'BioMérieux SA', 'Idexx Reference Laboratories', 'Randox Laboratories Ltd.', 'VCA, Inc.', 'Covance Inc.', 'IDVet', 'INGENASA', 'Creative Diagnostics', 'Eurofins Scientific SE', 'ProtaTek International Inc.', 'Agrolabo S.p.A.', 'Fujirebio Inc.', 'Bio-Rad Laboratories, Inc.'

At least 30 serious illnesses that affect people can be spread by animals. The majority of human infections are spread by livestock and companion animals (like dogs and cats) (such as pigs, chickens, cattle, goats, and camels). Major zoonotic illnesses that spread from animals to people include rabies, leptospirosis, cysticercosis, zoonotic tuberculosis, and gastrointestinal disease.

A number of zoonotic and vector-borne diseases are likely to become more common in the near future as a result of shifting social norms, habitat modification, the introduction of exotic vectors, and climate change. The need for quick and accurate diagnostic tools to stop these diseases will therefore drive the development of veterinary infectious disease diagnostics. According to the forecast, the development of companion animal medicine in developed nations will lead to further growth in the global market for veterinary infectious disease diagnostics. Furthermore, there is already a greater market demand for technologically advanced diagnostic techniques like RT PCR than there is for traditional diagnostic techniques.

Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary immunodiagnostics market. The expansion of products on the market, the sizable stakes held by the major players in the area, and the rising accessibility and affordability of early detection all contribute to this dominance. The market in Asia Pacific is anticipated to expand at the fastest rate during the forecast period due to rising pet adoption rates, zoonotic disease occurrences, and a rise in the need for diagnostics for infectious diseases in livestock.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Veterinary Immunodiagnostics Market

Product ID: SQMIG35I2291

$5,300
BUY NOW GET FREE SAMPLE